Use of Anodal tDCS to Enhance Upper Limb Recovery in Stroke

This will be a randomized, blinded, sham-controlled trial. The medical device used, Soterix Medical 1x1 tDCS stimulator, is capable of delivering either real or sham tDCS and has been used in many randomised controlled trials in stroke patients. 50 patients with subacute stroke and severe upper limb weakness within 8 weeks of stroke on transfer to TTSH stroke rehab wards will be recruited over a period of 10 months. Recruited patients will be randomized into the intervention and control arms in a 1:1 ratio.

NCT Number	NCT07151729
Lead Sponsor	Tan Tock Seng Hospital Collaborators: Ng Teng Fong Healthcare Innovation Programme
Conditions	Stroke
Enrollment	50 participants
Start Date	2025-09-01
Primary Completion	2026-09-15 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-09-03